TFA
SGHT icon

Transamerica Financial Advisors’s Sight Sciences SGHT Stock Holding History

Transamerica Financial Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64 Sell
17
-43
-72% -$232 ﹤0.01% 1823
2025
Q4 		$476 Buy
+60
New +$383 ﹤0.01% 1373

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Transamerica Financial Advisors's SGHT Position: Q1 2026 in Review

Transamerica Financial Advisors reduced its Sight Sciences (SGHT) stake by 72% in Q1 2026, selling an estimated $232 and leaving 17 shares worth $64. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Transamerica Financial Advisors first reported a position in SGHT in Q4 2025 and has held it in 2 quarters since. The position peaked at $476 in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Transamerica Financial Advisors held 17 shares of Sight Sciences worth $64 as of Q1 2026.
  • Transamerica Financial Advisors sold 43 Sight Sciences shares in Q1 2026, an estimated $232.
  • Sight Sciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1823 holding.
  • Transamerica Financial Advisors first reported a position in Sight Sciences in Q4 2025 and has held it in 2 quarters since.
  • Transamerica Financial Advisors's Sight Sciences position peaked at $476 in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.